A Phase 1, Placebo-Controlled, Randomized Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Following Multiple Intravenous Doses Of PF-04950615 (RN316) In Healthy Adult Subjects With Hypercholesterolemia.
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2012
At a glance
- Drugs Bococizumab (Primary)
- Indications Hypercholesterolaemia
- Focus Adverse reactions
- 07 Nov 2012 Results presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 09 Jul 2012 Official Title amended as reported by ClinicalTrials.gov.
- 22 Feb 2012 Actual patient numbers amended from 67 to 68 as reported by ClinicalTrials.gov.